Advertisement

Electrolytic Abnormalities Related to Potassium in Critically Ill Cancer Patients

  • Agamenón Quintero
  • Jorge RacedoEmail author
  • Aaron Rafael Quintero Hernández
Reference work entry

Abstract

Potassium homeostasis is vital to maintaining some physiological processes such as cell growth, nucleic acids, and protein synthesis, regulation of cell volume, acid-base balance, enzyme activation, and maintenance of resting membrane potential for cellular excitability. Potassium abnormalities are significant metabolic emergencies in the oncologic ICU patient. They are associated with life-threatening complications, higher mortality rates, and longer length of stay. Cancer patients are at particular risk due to the underlying malignancy, prescribed drugs, chemotherapy and radiotherapy, ICU-related treatment, surgery, and other metabolic impairments. Intensivists must be aware because hyperkalemia and hypokalemia can remain asymptomatic in some patients.

Keywords

Chronic kidney disease Hyperkalemia Hypokalemia Intensive critical care Oncologic emergency Potassium homeostasis 

References

  1. 1.
    Adrogué HJ, Madias NE. Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med. 1981;71(3):456–67. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7025622CrossRefGoogle Scholar
  2. 2.
    Adrogué HJ, et al. Determinants of plasma potassium levels in diabetic ketoacidosis. Medicine. 1986;65(3):163–72. Available at: http://www.ncbi.nlm.nih.gov/pubmed/3084904CrossRefGoogle Scholar
  3. 3.
    Allon M. Hyperkalemia in end-stage renal disease: mechanisms and management. J Am Soc Nephrol. 1995;6(4):1134–42. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8589279PubMedGoogle Scholar
  4. 4.
    An JN, et al. Severe hyperkalemia requiring hospitalization: predictors of mortality. Crit Care. 2012;16(6):R225. Available at: http://www.ncbi.nlm.nih.gov/pubmed/23171442CrossRefGoogle Scholar
  5. 5.
    Aronson PS, Giebisch G. Effects of pH on potassium: new explanations for old observations. J Am Soc Nephrol. 2011;22(11):1981–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21980112CrossRefGoogle Scholar
  6. 6.
    Atsmon J, Dolev E. Drug-induced hypomagnesaemia. Drug Saf. 2005;28(9):763–88. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16119971CrossRefGoogle Scholar
  7. 7.
    Barri YM, Knochel JP. Hypercalcemia and electrolyte disturbances in malignancy. Hematol Oncol Clin North Am. 1996;10(4):775–90. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8811300CrossRefGoogle Scholar
  8. 8.
    Belay Y, Yirdaw K, Enawgaw B. Tumor lysis syndrome in patients with hematological malignancies. J Oncol. 2017;2017:9684909. Available at: http://www.ncbi.nlm.nih.gov/pubmed/29230244CrossRefGoogle Scholar
  9. 9.
    Blum KA, et al. Risk factors for tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with the cyclin-dependent kinase inhibitor, flavopiridol. Leukemia. 2011;25:1444.  https://doi.org/10.1038/leu.2011.109.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Bowman BT. Electrolyte disorders associated with cancer. J Onco-Nephrol. 2017;1(1):30–5.CrossRefGoogle Scholar
  11. 11.
    Cho KC. Electrolyte & acid-base disorders. In: Papadakis MA, McPhee SJ, Rabow MW, editors. Current medical diagnosis & treatment 2019. New York: McGraw-Hill Education; 2019.Google Scholar
  12. 12.
    Choi MJ, Ziyadeh FN. The utility of the transtubular potassium gradient in the evaluation of hyperkalemia. J Am Soc Nephrol. 2008;19(3):424–6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18216310CrossRefGoogle Scholar
  13. 13.
    Collins AJ, et al. Association of serum potassium with all-cause mortality in patients with and without heart failure, chronic kidney disease, and/or diabetes. Am J Nephrol. 2017;46(3):213–21. Available at: http://www.ncbi.nlm.nih.gov/pubmed/28866674CrossRefGoogle Scholar
  14. 14.
    Gilbert SJ, Wright S. Tumor lysis syndrome. In: Jhaveri KD, Salahudeen AK, editors. Onconephrology: cancer, chemotherapy and the kidney. New York: Springer New York; 2015. p. 163–81.  https://doi.org/10.1007/978-1-4939-2659-6_8.CrossRefGoogle Scholar
  15. 15.
    Gonick HC, et al. Functional impairment in chronic renal disease. 3. Studies of potassium excretion. Am J Med Sci. 1971;261(5):281–90. Available at: http://www.ncbi.nlm.nih.gov/pubmed/5092154CrossRefGoogle Scholar
  16. 16.
    Hande KR, Garrow GC. Acute tumor lysis syndrome in patients with high-grade non-Hodgkin’s lymphoma. Am J Med. 1993;94(2):133–9. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8430709CrossRefGoogle Scholar
  17. 17.
    Izzedine H, et al. Hypokalemia, metabolic alkalosis, and hypertension in a lung cancer patient. Kidney Int. 2009;76(1):115–20. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18813287CrossRefGoogle Scholar
  18. 18.
    Lahoti A, Carreras MTC, Salahudeen AK. Nephro-urologic emergencies in patients with cancer. In: Manzullo EF, et al., editors. Oncologic emergencies. New York: Springer New York; 2016. p. 143–60.  https://doi.org/10.1007/978-1-4939-3188-0_6.CrossRefGoogle Scholar
  19. 19.
    Latcha S. Electrolyte disorders in cancer patients. In: Jhaveri KD, Salahudeen AK, editors. Onconephrology: cancer, chemotherapy and the kidney. New York: Springer New York; 2015a. p. 131–62.  https://doi.org/10.1007/978-1-4939-2659-6_7.CrossRefGoogle Scholar
  20. 20.
    Latcha S. Electrolyte disorders in cancer patients. In: Onconephrology. New York: Springer New York; 2015b. p. 131–62.Google Scholar
  21. 21.
    Latcha S. Electrolyte disorders in critically ill patients. In: Oropello JM, Pastores SM, Kvetan V, editors. Critical care. New York: McGraw-Hill Education; 2016.Google Scholar
  22. 22.
    LeBlond RF, et al. Common laboratory tests. In: DeGowin’s diagnostic examination. 10th ed. New York: McGraw-Hill Education; 2015.Google Scholar
  23. 23.
    Mahon SM, Casperson DS. Pathophysiology of hypokalemia in patients with cancer: implications for nurses. Oncol Nurs Forum. 1993;20(6):937–46; quiz 947–8. Available at: http://www.ncbi.nlm.nih.gov/pubmed/8367346PubMedGoogle Scholar
  24. 24.
    Maurea N, Parrini I, Lestuzzi C. Arrhythmias and electrolyte imbalances as consequences of cancer. In: Lestuzzi C, Oliva S, Ferraù F, editors. Manual of cardio-oncology: cardiovascular care in the cancer patient. Cham: Springer International Publishing; 2017. p. 75–88.  https://doi.org/10.1007/978-3-319-40236-9_5.CrossRefGoogle Scholar
  25. 25.
    McMahon GM, et al. Association between hyperkalemia at critical care initiation and mortality. Intensive Care Med. 2012;38(11):1834–42.  https://doi.org/10.1007/s00134-012-2636-7.CrossRefPubMedGoogle Scholar
  26. 26.
    Miltiadous G, et al. Causes and mechanisms of acid–base and electrolyte abnormalities in cancer patients. Eur J Intern Med. 2008;19(1):1–7.CrossRefGoogle Scholar
  27. 27.
    Montesinos P, et al. Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model. Haematologica. 2008;93(1):67–74. Available at: http://www.ncbi.nlm.nih.gov/pubmed/18166787.CrossRefGoogle Scholar
  28. 28.
    Mount DB. Fluid and electrolyte disturbances. In: Jameson JL, et al., editors. Harrison’s principles of internal medicine. 20th ed. New York: McGraw-Hill Education; 2018.Google Scholar
  29. 29.
    Nicolis GL, et al. Glucose-induced hyperkalemia in diabetic subjects. Arch Intern Med. 1981;141(1):49–53. Available at: http://www.ncbi.nlm.nih.gov/pubmed/7447584CrossRefGoogle Scholar
  30. 30.
    Ong H-Y. Clinical hyperkalemia and hypokalemia. In: Blakeley S, editor. Renal failure and replacement therapies. London: Springer London; 2008. p. 71–6.  https://doi.org/10.1007/978-1-84628-937-8_13.CrossRefGoogle Scholar
  31. 31.
    Paltiel O, et al. Management of severe hypokalemia in hospitalized patients. Arch Intern Med. 2001;161(8):1089.CrossRefGoogle Scholar
  32. 32.
    Phillips BM, et al. Severe hyperkalaemia: demographics and outcome. Clin Kidney J. 2014;7(2):127–33. Available at: http://www.ncbi.nlm.nih.gov/pubmed/25852860.CrossRefGoogle Scholar
  33. 33.
    Reddi AS. Disorders of potassium: hyperkalemia. In: Fluid, electrolyte and acid-base disorders: clinical evaluation and management. New York: Springer New York; 2014a. p. 177–91.  https://doi.org/10.1007/978-1-4614-9083-8_16.CrossRefGoogle Scholar
  34. 34.
    Reddi AS. Disorders of potassium: hypokalemia. In: Fluid, electrolyte and acid-base disorders: clinical evaluation and management. New York: Springer New York; 2014b. p. 161–76.  https://doi.org/10.1007/978-1-4614-9083-8_15.CrossRefGoogle Scholar
  35. 35.
    Reddi AS. Disorders of potassium: physiology. In: Fluid, electrolyte and acid-base disorders: clinical evaluation and management. New York: Springer New York; 2014c. p. 151–9.  https://doi.org/10.1007/978-1-4614-9083-8_14.CrossRefGoogle Scholar
  36. 36.
    Rosner MH, Capasso G, Perazella MA. Acute kidney injury and electrolyte disorders in the critically ill patient with cancer. Curr Opin Crit Care. 2017;23(6):475–83.CrossRefGoogle Scholar
  37. 37.
    Safavi M, et al. Hypokalemia at the time of admission to the intensive care unit (ICU) increases the need for mechanical ventilation and time of ventilation in critically ill trauma patients. Adv Biomed Res. 2017;6:50. Available at: http://www.ncbi.nlm.nih.gov/pubmed/28620594.CrossRefGoogle Scholar
  38. 38.
    Segal A. Potassium and the Dyskalemias. In: Core concepts in the disorders of fluid, electrolytes and acid-base balance. Boston: Springer US; 2013. p. 49–102.CrossRefGoogle Scholar
  39. 39.
    Todi S, Chawla R. Hypokalemia and hyperkalemia. In: Chawla R, Todi S, editors. ICU protocols: a stepwise approach. India: Springer India; 2012. p. 447–54.  https://doi.org/10.1007/978-81-322-0535-7_57.CrossRefGoogle Scholar
  40. 40.
    Viera AJ, Wouk N. Potassium disorders: hypokalemia and hyperkalemia. Am Fam Physician. 2015;92(6):487–95. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26371733PubMedGoogle Scholar
  41. 41.
    Yeung S-CJ. Endocrine and metabolic emergencies. In: Todd KH, Thomas Jr CR, editors. Oncologic emergency medicine: principles and practice. Cham: Springer International Publishing; 2016. p. 243–62.  https://doi.org/10.1007/978-3-319-26387-8_21.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Agamenón Quintero
    • 1
  • Jorge Racedo
    • 1
    Email author
  • Aaron Rafael Quintero Hernández
    • 1
    • 2
  1. 1.Department of Critical Care MedicineInstituto Médico de Alta Tecnología IMAT OncomedicaMonteríaColombia
  2. 2.School of MedicineUniversidad del SinúMonteríaColombia

Personalised recommendations